Disclosures for "The Safety and Efficacy of Subcutaneous Forms of Levodopa/Carbidopa (ND0612 and Foslevodopa/ Foscarbidopa) on Parkinson’s Disease Patients: Systematic Review and Meta Analysis"
-
Dr. Fathy has nothing to disclose.
-
Ms. Ibrahim has nothing to disclose.
-
Dr. Al Haj Ali has nothing to disclose.
-
Mr. Saad has nothing to disclose.
-
Dr. Abd El Aziz has nothing to disclose.
-
Dr. Nasser has nothing to disclose.
-
Dr. Hegazy has nothing to disclose.
-
Dr. Shaheen has a non-compensated relationship as a A Research Position Candidate Under Trial Task with Solvemed Company that is relevant to AAN interests or activities.
-
Dr. Saha has nothing to disclose.